Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury.

Welch RD, Ayaz SI, Lewis LM, Unden J, Chen JY, Mika VH, Saville B, Tyndall JA, Nash M, Buki A, Barzo P, Hack D, Tortella FC, Schmid K, Hayes RL, Vossough A, Sweriduk ST, Bazarian JJ.

J Neurotrauma. 2016 Jan 15;33(2):203-14. doi: 10.1089/neu.2015.4149. Epub 2015 Dec 18.

2.

Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.

Welch RD, Ellis M, Lewis LM, Ayaz SI, Mika VH, Millis S, Papa L.

J Neurotrauma. 2017 Jun 1;34(11):1957-1971. doi: 10.1089/neu.2016.4772. Epub 2017 Feb 27.

PMID:
28031000
3.

Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.

Lewis LM, Schloemann DT, Papa L, Fucetola RP, Bazarian J, Lindburg M, Welch RD.

Acad Emerg Med. 2017 Jun;24(6):710-720. doi: 10.1111/acem.13174. Epub 2017 May 18.

4.

Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.

Diaz-Arrastia R, Wang KK, Papa L, Sorani MD, Yue JK, Puccio AM, McMahon PJ, Inoue T, Yuh EL, Lingsma HF, Maas AI, Valadka AB, Okonkwo DO, Manley GT; TRACK-TBI Investigators.

J Neurotrauma. 2014 Jan 1;31(1):19-25. doi: 10.1089/neu.2013.3040. Epub 2013 Oct 9.

5.

The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.

Posti JP, Takala RS, Runtti H, Newcombe VF, Outtrim J, Katila AJ, Frantzén J, Ala-Seppälä H, Coles JP, Hossain MI, Kyllönen A, Maanpää HR, Tallus J, Hutchinson PJ, van Gils M, Menon DK, Tenovuo O.

Neurosurgery. 2016 Sep;79(3):456-64. doi: 10.1227/NEU.0000000000001226.

PMID:
26963330
6.

Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 as Outcome Predictors in Traumatic Brain Injury.

Takala RS, Posti JP, Runtti H, Newcombe VF, Outtrim J, Katila AJ, Frantzén J, Ala-Seppälä H, Kyllönen A, Maanpää HR, Tallus J, Hossain MI, Coles JP, Hutchinson P, van Gils M, Menon DK, Tenovuo O.

World Neurosurg. 2016 Mar;87:8-20. doi: 10.1016/j.wneu.2015.10.066. Epub 2015 Nov 10.

PMID:
26547005
7.

Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study.

Mondello S, Papa L, Buki A, Bullock MR, Czeiter E, Tortella FC, Wang KK, Hayes RL.

Crit Care. 2011 Jun 24;15(3):R156. doi: 10.1186/cc10286.

8.

Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury.

Mondello S, Kobeissy F, Vestri A, Hayes RL, Kochanek PM, Berger RP.

Sci Rep. 2016 Jun 20;6:28203. doi: 10.1038/srep28203.

9.

Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury.

Papa L, Brophy GM, Welch RD, Lewis LM, Braga CF, Tan CN, Ameli NJ, Lopez MA, Haeussler CA, Mendez Giordano DI, Silvestri S, Giordano P, Weber KD, Hill-Pryor C, Hack DC.

JAMA Neurol. 2016 May 1;73(5):551-60. doi: 10.1001/jamaneurol.2016.0039.

PMID:
27018834
10.

In Children and Youth with Mild and Moderate Traumatic Brain Injury, Glial Fibrillary Acidic Protein Out-Performs S100β in Detecting Traumatic Intracranial Lesions on Computed Tomography.

Papa L, Mittal MK, Ramirez J, Ramia M, Kirby S, Silvestri S, Giordano P, Weber K, Braga CF, Tan CN, Ameli NJ, Lopez M, Zonfrillo M.

J Neurotrauma. 2016 Jan 1;33(1):58-64. doi: 10.1089/neu.2015.3869. Epub 2015 Jun 3.

11.

Prospective Assessment of Acute Blood Markers of Brain Injury in Sport-Related Concussion.

Meier TB, Nelson LD, Huber DL, Bazarian JJ, Hayes RL, McCrea MA.

J Neurotrauma. 2017 Nov 15;34(22):3134-3142. doi: 10.1089/neu.2017.5046. Epub 2017 Aug 4.

PMID:
28699381
12.

Neuronal Biomarker Ubiquitin C-Terminal Hydrolase Detects Traumatic Intracranial Lesions on Computed Tomography in Children and Youth with Mild Traumatic Brain Injury.

Papa L, Mittal MK, Ramirez J, Silvestri S, Giordano P, Braga CF, Tan CN, Ameli NJ, Lopez MA, Haeussler CA, Mendez Giordano D, Zonfrillo MR.

J Neurotrauma. 2017 Jul 1;34(13):2132-2140. doi: 10.1089/neu.2016.4806. Epub 2017 Apr 18.

13.

Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study.

Bazarian JJ, Biberthaler P, Welch RD, Lewis LM, Barzo P, Bogner-Flatz V, Gunnar Brolinson P, Büki A, Chen JY, Christenson RH, Hack D, Huff JS, Johar S, Jordan JD, Leidel BA, Lindner T, Ludington E, Okonkwo DO, Ornato J, Peacock WF, Schmidt K, Tyndall JA, Vossough A, Jagoda AS.

Lancet Neurol. 2018 Sep;17(9):782-789. doi: 10.1016/S1474-4422(18)30231-X. Epub 2018 Jul 24.

PMID:
30054151
14.

Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.

Huang XJ, Glushakova O, Mondello S, Van K, Hayes RL, Lyeth BG.

J Neurotrauma. 2015 Aug 15;32(16):1179-89. doi: 10.1089/neu.2015.3873. Epub 2015 May 14.

PMID:
25763798
15.

Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury.

Mondello S, Jeromin A, Buki A, Bullock R, Czeiter E, Kovacs N, Barzo P, Schmid K, Tortella F, Wang KK, Hayes RL.

J Neurotrauma. 2012 Apr 10;29(6):1096-104. doi: 10.1089/neu.2011.2092.

16.

GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions.

Papa L, Silvestri S, Brophy GM, Giordano P, Falk JL, Braga CF, Tan CN, Ameli NJ, Demery JA, Dixit NK, Mendes ME, Hayes RL, Wang KK, Robertson CS.

J Neurotrauma. 2014 Nov 15;31(22):1815-22. doi: 10.1089/neu.2013.3245. Epub 2014 Sep 12.

17.

Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging.

McMahon PJ, Panczykowski DM, Yue JK, Puccio AM, Inoue T, Sorani MD, Lingsma HF, Maas AI, Valadka AB, Yuh EL, Mukherjee P, Manley GT, Okonkwo DO; TRACK-TBI Investigators.

J Neurotrauma. 2015 Apr 15;32(8):527-33. doi: 10.1089/neu.2014.3635. Epub 2015 Jan 26.

18.

GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome.

Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H.

J Neurotrauma. 2004 Nov;21(11):1553-61.

PMID:
15684648
19.

Performance of Glial Fibrillary Acidic Protein in Detecting Traumatic Intracranial Lesions on Computed Tomography in Children and Youth With Mild Head Trauma.

Papa L, Zonfrillo MR, Ramirez J, Silvestri S, Giordano P, Braga CF, Tan CN, Ameli NJ, Lopez M, Mittal MK.

Acad Emerg Med. 2015 Nov;22(11):1274-82. doi: 10.1111/acem.12795. Epub 2015 Oct 15.

20.

Glial fibrillary acidic protein is highly correlated with brain injury.

Lumpkins KM, Bochicchio GV, Keledjian K, Simard JM, McCunn M, Scalea T.

J Trauma. 2008 Oct;65(4):778-82; discussion 782-4. doi: 10.1097/TA.0b013e318185db2d.

PMID:
18849790

Supplemental Content

Support Center